EIF2AK2 and familial pancreatic carcinoma: For example, in pancreatic cancer (PAAD study, TCGA pancreatic cancer database, 196 cases), EIF2AK2 expression is considered as an unfavorable prognostic marker2; and data depiction with the UCSC Xena browser shows a negative correlation between PKR expression and survival (p = 0.001, Figure 4C).